Diabetic nephropathy and microalbuminuria in pregnant women with type 1 and type 2 diabetes: Prevalence, antihypertensive strategy, and pregnancy outcome

Diabetes Care

Volumn 36, Issue 11, 2013, Pages 3489-3494

  Damm, Julie Agner ^a   Ásbjörnsdóttir, Björg ^a   Callesen, Nicoline Foged ^a   Mathiesen, Jonathan M ^a   Ringholm, Lene ^a   Pedersen, Berit Woetmann ^a   Mathiesen, Elisabeth R ^a,b  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LABETALOL; METHYLDOPA; NIFEDIPINE; ANTIHYPERTENSIVE AGENT; GLUCOSE BLOOD LEVEL;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; CESAREAN SECTION; CLINICAL EVALUATION; CONGENITAL HEART MALFORMATION; DIABETIC NEPHROPATHY; DRUG RESPONSE; DRUG USE; FEMALE; GESTATIONAL AGE; GLYCEMIC CONTROL; HORMONE SUBSTITUTION; HUMAN; HYPOSPADIAS; INSULIN DEPENDENT DIABETES MELLITUS; INTRAUTERINE GROWTH RETARDATION; LABOR INDUCTION; LOW DRUG DOSE; MACROSOMIA; MAJOR CLINICAL STUDY; MICROALBUMINURIA; MULTIPLE MALFORMATION SYNDROME; NON INSULIN DEPENDENT DIABETES MELLITUS; PLACENTA INSUFFICIENCY; PREECLAMPSIA; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PREVALENCE; RETROSPECTIVE STUDY; YOUNG ADULT; ALBUMINURIA; COHORT ANALYSIS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; GLUCOSE BLOOD LEVEL; PREGNANCY; PREGNANCY IN DIABETICS;

ADULT; ALBUMINURIA; ANTIHYPERTENSIVE AGENTS; BLOOD GLUCOSE; BLOOD PRESSURE; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; PREGNANCY; PREGNANCY IN DIABETICS; PREGNANCY OUTCOME; PREVALENCE; YOUNG ADULT;

EID: 84891870136     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-1031     Document Type: Article

References (40)

1. Dart AB, Sellers EA, Dean HJ. Kidney disease and youth onset type 2 diabetes: considerations for the general practitioner. Int J Pediatr 2012;2012:237360
2. Clausen TD, Mathiesen E, Ekbom P, Hellmuth E, Mandrup-Poulsen T, Damm P. Poor pregnancy outcome in women with type 2 diabetes. Diabetes Care 2005; 28:323-328
3. Eppens MC, Craig ME, Jones TW, Silink M, Ong S, Ping YJ; International Diabetes Federation Western Pacific Region Steering Committee. Type 2 diabetes in youth from the Western Pacific region: glycaemic control, diabetes care and complications. Curr Med Res Opin 2006;22: 1013-1020
4. Scott A, Toomath R, Bouchier D, et al. First national audit of the outcomes of care in young people with diabetes in New Zealand: high prevalence of nephropathy in Maori and Pacific Islanders. N Z Med J 2006;119:U2015
5. Maahs DM, Snively BM, Bell RA, et al. Higher prevalence of elevated albumin excretion in youth with type 2 than type 1 diabetes: the SEARCH for Diabetes in Youth study. Diabetes Care 2007;30:2593-2598
6. Dart AB, Sellers EA, Martens PJ, Rigatto C, Brownell MD, Dean HJ. High burden of kidney disease in youth-onset type 2 diabetes. Diabetes Care 2012;35:1265-1271
7. Landon MB. Diabetic nephropathy and pregnancy. Clin Obstet Gynecol 2007;50: 998-1006
8. Murphy HR, Steel SA, Roland JM, et al. Obstetric and perinatal outcomes in pregnancies complicated by type 1 and type 2 diabetes: influences of glycaemic control, obesity and social disadvantage. Diabet Med 2011;28:1060-1067
9. Bell R, Glinianaia SV, Tennant PW, Bilous RW, Rankin J. Peri-conception hyperglycaemia and nephropathy are associated with risk of congenital anomaly with pre-existing diabetes: a population-based cohort study. Diabetologia 2012;55:936-947
10. Kitzmiller JL, Combs CA. Diabetic nephropathy and pregnancy. Obstet Gynecol Clin North Am 1996;23:173-203
11. Jovanovic L, Inturissi M. Assessment of glycemic control. In Managing Preexisting Diabetes Mellitus for Pregnancy. Kitzmiller JL, Ed. Alexandria, VA, AmericanDiabetes Association, 2008, p. 379-386
12. Ekbom P, Damm P, Feldt-Rasmussen B, Feldt-Rasmussen U, Mølvig J, Mathiesen ER. Pregnancy outcome in type 1 diabetic women with microalbuminuria. Diabetes Care 2001;24:1739-1744
13. Dunne FP, Chowdhury TA, Hartland A, et al. Pregnancy outcome in women with insulin-dependent diabetes mellitus complicated by nephropathy. QJM 1999;92: 451-454
14. Nielsen LR,Muller C, DammP,Mathiesen ER. Reduced prevalence of early preterm delivery in women with type 1 diabetes and microalbuminuriadpossible effect of early antihypertensive treatment during pregnancy. Diabet Med 2006;23:426-431
15. Parving HH, Smidt UM, Hommel E, et al. Effective antihypertensive treatment postpones renal insufficiency in diabetic nephropathy. Am J Kidney Dis 1993;22: 188-195
16. Mathiesen ER,Hommel E, Giese J, Parving HH. Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. BMJ 1991;303:81-87
17. Mathiesen ER, Hommel E, Hansen HP, Parving HH. Randomised controlled trial of long term efficacy of captopril on preservation of kidney function in normotensive patients with insulin dependent diabetes andmicroalbuminuria. BMJ 1999; 319:24-25
18. American Diabetes Association. Standards of medical care in diabetes 2012. Diabetes Care 2012;35(Suppl. 1):S11-S63
19. Mathiesen ER, Rønn B, Storm B, Foght H, Deckert T. The natural course of microalbuminuria in insulin-dependent diabetes: a 10-year prospective study. Diabet Med 1995;12:482-487
20. National Institute for Health and Clinical Excellence. Guidance: Hypertension in Pregnancy: The Management of Hypertensive Disorders During Pregnancy. London, National Institute for Health and Clinical Excellence, 2010
21. Magee LA, Abalos E, von Dadelszen P, Sibai B, Easterling T, Walkinshaw S; CHIPS Study Group. How to manage hypertension in pregnancy effectively. Br J Clin Pharmacol 2011;72:394-401
22. Nielsen LR, Damm P, Mathiesen ER. Improved pregnancy outcome in type 1 diabetic women with microalbuminuria or diabetic nephropathy: effect of intensified antihypertensive therapy? Diabetes Care 2009;32:38-44
23. Brown CM, Garovic VD. Mechanisms and management of hypertension in pregnant women. Curr Hypertens Rep 2011;13: 338-346
24. Justesen TI, Petersen JL, Ekbom P, DammP, Mathiesen ER. Albumin-to-creatinine ratio in random urine samplesmight replace 24-h urine collections in screening for micro-and macroalbuminuria in pregnant woman with type 1 diabetes. Diabetes Care 2006; 29:924-925
25. Nielsen LR, Pedersen-Bjergaard U, Thorsteinsson B, Johansen M, Damm P, Mathiesen ER. Hypoglycemia in pregnant women with type 1 diabetes: predictors and role of metabolic control. Diabetes Care 2008;31:9-14
26. Feldt-Rasmussen B, Dinesen B, Deckert M. Enzyme immunoassay: an improved determination of urinary albumin in diabetics with incipient nephropathy. Scand J Clin Lab Invest 1985;45:539-544
27. Montan S, Anandakumar C, Arulkumaran S, Ingemarsson I, Ratnam SS. Effects of methyldopa on uteroplacental and fetal hemodynamics in pregnancy-induced hypertension. Am J Obstet Gynecol 1993; 168:152-156
28. Marsal K, Persson PH, Larsen T, Lilja H, Selbing A, Sultan B. Intrauterine growth curves based on ultrasonically estimated foetal weights. Acta Paediatr 1996;85: 843-848
29. McCance DR, Holmes VA, Maresh MJA, et al.; Diabetes and Pre-eclampsia Intervention Trial (DAPIT) Study Group. Vitamins C and E for prevention of preeclampsia in women with type 1 diabetes (DAPIT): a randomised placebo-controlled trial. Lancet 2010;376:259-266
30. Jensen DM, Damm P, Ovesen P, et al. Microalbuminuria, preeclampsia, and pretermdelivery in pregnant women with type 1 diabetes: results from a nationwide Danish study. Diabetes Care 2010;33:90-94
31. Cundy T, Slee F, Gamble G, Neale L. Hypertensive disorders of pregnancy in women with type 1 and type 2 diabetes. Diabet Med 2002;19:482-489
32. Hovind P, Tarnow L, Rossing K, et al. Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care 2003;26:1258-1264
33. Feldt-Rasmussen B, Mathiesen ER, Deckert T. Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes. Lancet 1986;2:1300-1304
34. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329: 977-986
35. Bar J, Chen R, Schoenfeld A, et al. Pregnancy outcome in patients with insulin dependent diabetes mellitus and diabetic nephropathy treated with ACE inhibitors before pregnancy. J Pediatr Endocrinol Metab 1999;12:659-665
36. Holmes VA, Young IS, Patterson CC, et al.; Diabetes and Pre-eclampsia Intervention Trial Study Group. Optimal glycemic control, pre-eclampsia, and gestational hypertension in womenwith type 1 diabetes in the Diabetes and Pre-eclampsia Intervention Trial. Diabetes Care 2011;34: 1683-1688
37. Carr DB, Koontz GL, Gardella C, et al. Diabetic nephropathy in pregnancy: suboptimal hypertensive control associated with preterm delivery. Am J Hypertens 2006;19:513-519
38. Rossing K, Jacobsen P, Hommel E, et al. Pregnancy and progression of diabetic nephropathy. Diabetologia 2002;45:36-41
39. Haeri S, Khoury J, Kovilam O, Miodovnik M. The association of intrauterine growth abnormalities in women with type 1 diabetes mellitus complicated by vasculopathy. AmJ Obstet Gynecol 2008;199:278. e1-5
40. WallenburgHC, Dekker GA,Makovitz JW, Rotmans P. Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae. Lancet 1986;1:1-3